Tolterodine Relieves Overactive Bladder Symptoms in Women With Moderate-to-severe Obstructive Sleep Apnea Syndrome
NCT ID: NCT05250245
Last Updated: 2022-02-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
60 participants
INTERVENTIONAL
2020-06-01
2022-01-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Nasal Versus Oronasal Mask in Continuous Positive Airway Pressure (CPAP) Treatment of Patients Affected by Obstructive Sleep Apnea Syndrome (OSAS).
NCT04681196
Continuous Positive Airway Pressure (CPAP) for Primary Care
NCT02459548
Comparison of Two Techniques of Combination Therapy for Treatment of Obstructive Sleep Apnea (OSA)
NCT04029311
Home Nasal Pressure for Sleep Apnea Management in Primary Case
NCT02141165
Respiratory Muscle Training Combined With Aerobic Exercise in Obstructive Sleep Apnea Syndrome
NCT05210998
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
CPAP only group
Patients who are going to receive only CPAP treatment for their moderate-to-severe obstructive sleep apnea syndrome (OSAS)
Continuous positive airway pressure therapy (CPAP)
The gold standard for the treatment of confirmed OSAS is continuous positive airway pressure (CPAP) therapy
Combined use of CPAP and tolterodine
Patients who are going to receive combined use of CPAP and tolterodine 4mg a day treatment for their OSAS
Tolterodine Tartrate 4 MG
Tolterodine is actively being used in the treatment of over active bladder symptoms today
Continuous positive airway pressure therapy (CPAP)
The gold standard for the treatment of confirmed OSAS is continuous positive airway pressure (CPAP) therapy
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Tolterodine Tartrate 4 MG
Tolterodine is actively being used in the treatment of over active bladder symptoms today
Continuous positive airway pressure therapy (CPAP)
The gold standard for the treatment of confirmed OSAS is continuous positive airway pressure (CPAP) therapy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with AHI ≥15 (moderate or severe) and OAB-V8≥8 were considered eligible for the study and randomized in two groups to receive either CPAP treatment only or CPAP treatment with tolterodine tartrate
18 Years
60 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Yuzuncu Yıl University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Kasım Ertas
Assistant Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Yuzuncu Yıl University
Van, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
065
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.